Lavoltidine

DB12884InvestigationalSmall molecule

Lavoltidine has been used in trials studying the diagnostic of Reflux, Gastroesophageal and Gastroesophageal Reflux Disease.

Chemical structure of Lavoltidine
Formula / weight
C19H29N5O2 · 359.474 g/mol (avg)
Code names
AH-23844

Resolves to

Compound
UNIIX16K5179V5CAS76956-02-0ChEMBLCHEMBL2110857ChEBI6550PubChem55473KEGGC11805
Structure
InChIKeyVTLNPNNUIJHJQB-UHFFFAOYSA-NSMILESCN1N=C(CO)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1
Targets
P25021HRH2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
124Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Lavoltidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In